Repro Med Systems Inc (REPR)

[blue_skies]

the last presentation at ld micro did not produce any market reaction. Especially in terms of more volume and liquidity. So I do not expect much market reaction from this presentation. But things take time and Goldberger is putting the RMS on peoples radar. So that is a plus.

The presentation at ld micro and the stockholders meeting were virtually the same. So I would expect this presentation to be more of the same. Perhaps some tweaks? Small company with no debt, having a cost effective solution leading the charge into large and expanding markets. I have heard all this before.

So what is unique about about rms verse other infusion companies? what excites me more about the company's potential is the super26 and dynamic flow. The sales to pharma during drug evaluation studies is like going to the front of the line.